Bruker Corp

Bruker Corp

  • Price (USD)71.50
  • Today's Change-1.02 / -1.41%
  • Shares traded328.06k
  • 1 Year change+5.63%
  • Beta1.1417
Data delayed at least 15 minutes, as of Feb 06 2023 21:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Bruker Corporation is a developer, manufacturer, and distributor of scientific instruments and analytical and diagnostic solutions. The Company operates through four segments: Bruker BioSpin Group, Bruker CALID Group, Bruker Scientific Instruments (BSI) Nano Group and Bruker Energy & Supercon Technologies (BEST). The Bruker BioSpin Group segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. The Bruker CALID Group segment designs, manufactures, and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions. The BSI NANO Group segment designs and manufactures advanced X-ray instruments; advanced fluorescence optical microscopy instruments; analytical tools for electron microscopes and X-ray metrology; and defect-detection equipment. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices.

  • Revenue in USD (TTM)2.51bn
  • Net income in USD274.90m
  • Incorporated2000
  • Employees7.77k
  • Location
    Bruker Corp40 MANNING RDBILLERICA 01821United StatesUSA
  • Phone+1 (978) 663-3660
  • Fax+1 (978) 663-5585
  • Websitehttps://www.bruker.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BRKR:NSQ since
ACQUIFER Imaging GmbHDeal completed05 Jan 202305 Jan 2023Deal completed1.87%--
Biognosys AGDeal completed04 Jan 202304 Jan 2023Deal completed3.52%--
Neurescence IncDeal completed12 Nov 202212 Nov 2022Deal completed2.27%--
Inscopix IncDeal completed08 Nov 202208 Nov 2022Deal completed7.88%--
Ionsense IncDeal completed06 Apr 202206 Apr 2022Deal completed12.67%--
Data delayed at least 15 minutes, as of Feb 06 2023 21:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Olink Holding AB (publ) - ADR125.65m-26.16m2.37bn416.00--6.26--18.89-0.2197-0.21971.063.180.25361.594.79302,033.70-5.30---5.61--61.03---20.89--3.98--0.0235--75.66---79.66------
Itron Inc1.81bn-90.81m2.62bn5.64k--2.40--1.45-2.01-2.0140.1124.220.76546.926.17321,865.10-3.79-0.7379-4.87-0.978127.7230.17-4.96-0.80231.20-0.97270.288---8.82-0.3161-40.20---4.45--
Badger Meter Inc565.57m66.50m3.54bn1.84k53.408.0038.
Vontier Corp3.10bn446.00m3.71bn8.50k8.757.466.601.202.682.6818.903.150.73575.316.30365,023.5010.57--13.35--45.1143.4714.3714.321.109.790.8410.650510.584.6020.766.27----
Integra Lifesciences Holdings Corp1.57bn172.99m4.85bn3.80k28.262.8116.573.102.052.0518.5720.650.41291.816.45411,886.304.563.264.983.6163.1864.2111.057.362.917.050.47230.0012.439.2326.2817.790.3158--
MKS Instruments Inc3.22bn429.20m6.98bn6.00k13.651.6812.092.167.697.6956.4862.390.40982.395.48537,483.305.4511.306.0112.5843.9245.9313.3115.911.817.110.545912.1426.5917.8957.5039.3835.304.81
Cognex Corporation1.01bn213.75m9.41bn2.26k44.926.7740.339.311.211.215.738.030.51192.998.58447,816.6010.8315.1711.8016.4071.9674.2721.1528.484.21--0.0044.8727.8814.3958.8614.223.8210.68
Bruker Corporation2.51bn274.90m10.52bn7.77k39.1511.2528.954.201.831.8316.646.360.77521.656.32322,704.408.547.6811.8710.5051.1947.9411.019.571.4930.950.547512.9621.668.4675.6012.5319.920.00
Bio Rad Laboratories Inc2.80bn-6.03bn13.68bn7.90k--1.66--4.88-201.80-201.8093.97283.450.17521.936.60355,029.10-37.7024.42-39.2026.3656.1755.45-215.1683.244.300.0560.12410.0014.817.1611.55177.08-3.10--
Avantor Inc7.51bn662.30m15.79bn13.50k24.033.2514.792.100.97450.974511.067.200.54915.506.16--5.022.455.662.7634.6532.919.
PerkinElmer, Inc.4.57bn615.95m17.42bn16.70k28.352.4616.373.824.864.9936.0655.980.31794.036.13273,361.604.296.634.727.7054.8052.3113.4914.321.848.450.38396.5533.9519.0929.5534.3225.800.00
Waters Corporation2.95bn696.93m20.02bn7.80k29.3952.0924.136.7911.4711.4748.576.470.95373.015.20378,191.7022.5316.2029.1519.4457.5958.4823.6324.161.5523.490.80040.0017.785.1532.845.8512.12--
Fortive Corp5.83bn755.20m24.33bn18.00k32.882.5119.934.182.102.1016.1527.440.36014.696.17--4.674.685.835.7857.7356.6812.9614.790.711510.280.251314.3610.870.240730.27-1.50-2.920.00
Data as of Feb 06 2023. Currency figures normalised to Bruker Corp's reporting currency: US Dollar USD

Institutional shareholders

46.68%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Investment Management, Inc.as of 30 Sep 202216.40m11.15%
The Vanguard Group, Inc.as of 30 Sep 202210.80m7.35%
Fidelity Management & Research Co. LLCas of 30 Sep 202210.26m6.97%
BlackRock Fund Advisorsas of 30 Sep 20229.72m6.61%
Massachusetts Financial Services Co.as of 30 Sep 20227.23m4.92%
AllianceBernstein LPas of 30 Sep 20223.23m2.19%
SSgA Funds Management, Inc.as of 30 Sep 20223.14m2.14%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 20223.11m2.11%
MFS International (UK) Ltd.as of 30 Nov 20222.82m1.92%
Fuller & Thaler Asset Management, Inc.as of 30 Sep 20221.95m1.33%
More ▼
Data from 30 Sep 2022 - 31 Dec 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.